Author

Sara I Edwards

Institutions: Indiana University Health, Indiana University Melvin and Bren Simon Comprehensive Cancer Center

Observed institutions: Indiana University Health, Indiana University Melvin and Bren Simon Comprehensive Cancer Center

OpenAlex ID: A5028367464

Immunomodulation by HDAC inhibition: Results from a phase Ib study with vorinostat and pembrolizumab in metastatic urothelial, renal, and prostate carcinoma patients.

2019 · Roberto Pili, David I. Quinn, et al. · Journal of Clinical Oncology · 21

Clinical course of patients with cisplatin (CDDP)-associated neuropathy compared to other neurotoxic chemotherapy.

2019 · Costantine Albany, Travis Dockter, et al. · Journal of Clinical Oncology · 2

Works count: 2

Citation count: 23

H-index: 2

I10-index: 1